ANADYS
Anadys Pharmaceuticals is a biopharmaceutical company dedicated to developing medicines for the treatment of hepatitis C. The company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. Anadys has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.
ANADYS
Social Links:
Industry:
Biopharma Biotechnology Clinical Trials
Founded:
2000-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.anadyspharma.com
Total Employee:
11+
Status:
Closed
Total Funding:
17.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Sitelinks Search Box
Stock Details
Company's stock symbol is NASDAQ:ANDS
Official Site Inspections
http://www.anadyspharma.com Semrush global rank: 6.76 M Semrush visits lastest month: 816
- Host name: s128.cyber-folks.pl
- IP address: 185.204.218.114
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
Loading ...